Literature DB >> 12640160

Mesenteric neoplasms: CT appearances of primary and secondary tumors and differential diagnosis.

Sheila Sheth1, Karen M Horton, Melissa R Garland, Elliot K Fishman.   

Abstract

Computed tomography (CT) remains the optimal imaging modality for diagnosing tumors in the mesentery. Although primary neoplasms arising from the mesenchymal tissues of the mesentery are rare, the small bowel mesentery is a major avenue for the dissemination of tumor within the peritoneal cavity. Tumors spread to the mesentery by four major routes: (a) direct extension, commonly seen with carcinoid tumor of the small intestine as well as intraabdominal cancers such as pancreatic and colon cancer; (b) lymphatic dissemination of lymphoma and some epithelial malignancies; (c) hematogenic spread resulting in embolic metastases to the small intestinal wall, usually seen in melanoma and breast cancer; and (d) seeding through the peritoneum from ovarian and gastrointestinal malignancies as well as some lymphomas. Although percutaneous imaging-guided or surgical biopsy is often necessary to guide management, analysis of CT features along with the clinical history may be useful in differentiating mesenteric tumors from infectious, inflammatory, or vascular processes affecting the mesentery. The article presents the characteristic appearances of primary and secondary mesenteric neoplasms at CT and offers a rational approach to the differential diagnosis of mesenteric masses depicted at CT. Copyright RSNA, 2003

Entities:  

Mesh:

Year:  2003        PMID: 12640160     DOI: 10.1148/rg.232025081

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  41 in total

Review 1.  Mesenteric panniculitis: US and CT features.

Authors:  A C van Breda Vriesman; H M Schuttevaer; E G Coerkamp; J B C M Puylaert
Journal:  Eur Radiol       Date:  2004-08-05       Impact factor: 5.315

2.  An Unusual Finding on Screening Colonoscopy-Pancreatic Cancer.

Authors:  Diana L Franco; Suresh Pola; Derek Patel
Journal:  J Gastrointest Cancer       Date:  2012-09

3.  Peritoneal sarcoidosis: the role of imaging in diagnosis.

Authors:  Meghan G Lubner; Perry J Pickhardt
Journal:  Gastroenterol Hepatol (N Y)       Date:  2009-12

4.  CT diagnosis of 52 patients with lymphoma in abdominal lymph nodes.

Authors:  Ri-Sheng Yu; Wei-Min Zhang; Yi-Qing Liu
Journal:  World J Gastroenterol       Date:  2006-12-28       Impact factor: 5.742

5.  Should mesenteric tumor deposits be included in staging of well-differentiated small intestine neuroendocrine tumors?

Authors:  Raul S Gonzalez; Eric H Liu; JoAnn R Alvarez; Gregory D Ayers; M Kay Washington; Chanjuan Shi
Journal:  Mod Pathol       Date:  2014-01-24       Impact factor: 7.842

Review 6.  Misty mesentery: a pictorial review of multidetector-row CT findings.

Authors:  A Filippone; R Cianci; F Di Fabio; M L Storto
Journal:  Radiol Med       Date:  2010-12-03       Impact factor: 3.469

7.  Giardiasis: a malignant mimicker?

Authors:  Ozdemir Kanar; Rahman Nakshabendi; Faiz Jiwani; Yuzhou Liu; William Allsopp; Andrew C Berry
Journal:  Intern Emerg Med       Date:  2015-06-09       Impact factor: 3.397

8.  Sclerosing mesenteritis, a rare mesenteric disorder, in a patient with ulcerative colitis.

Authors:  Muhammad Zakir Hossain Khan; Yoshiaki Takeuchi; Chitose Ohishi; Takashi Hashizume; Takehiko Gokan; Michio Imawari
Journal:  Clin J Gastroenterol       Date:  2009-05-02

9.  Preferential attachment of peritoneal tumor metastases to omental immune aggregates and possible role of a unique vascular microenvironment in metastatic survival and growth.

Authors:  Scott A Gerber; Viktoriya Y Rybalko; Chad E Bigelow; Amit A Lugade; Thomas H Foster; John G Frelinger; Edith M Lord
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

10.  Pathways of abdominal tumour spread: the role of the subperitoneal space.

Authors:  Richard M Gore; Geraldine M Newmark; Kiran H Thakrar; Uday K Mehta; Jonathan W Berlin
Journal:  Cancer Imaging       Date:  2009-12-24       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.